Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Share this:

Mar 20, 2014 · Leave a Reply

Targeting Treatment for Ulcerative Colitis Patients

By Margaret Shepard, Communications Associate @Margaret_Marie

Sunanda Kane, M. D., discusses a recent study published in the Inflammatory Bowel Diseases journal about the feasibility of endoscopic assessment and targeting treatment for ulcerative colitis patients.

Patients with ulcerative colitis usually end up on medications like Humira or Remicade and wonder if the medications are doing any good. Researchers at the University of California at San Diego followed patients who were on either Humira of Remicade for a period of a year. The researchers were able to show that the colon can heal with repeated endoscopic tests and adjustments of medications.

If you have ulcerative colitis and are on either Humira or Remicade and feeling better, that's good news. The next step is to make sure the colon is healing. The only way to ensure the colon is healing is through endoscopy. This study shows that by monitoring what the colon looks like through endoscopy and adjustments of medications, doctors can reach the important end point of healing the colon.

Read the full article online here.

For more information about IBD, visit mayoclinic.org/ibd.

Dr. Kane is a gastroenterologist at Mayo Clinic.

Tags: endoscopy, IBD, Inflammatory Bowel Disease Journal, Study Findings, Sunanda Kane, ulcerative colitis

Please login or become a member to post a comment.

Contact Us · Privacy Policy